<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugRecordOutput id="8185"><DrugName>BCH-1788</DrugName><DrugSynonyms><Name><Value>BCH-1788</Value><Types><Type>Research Code</Type></Types></Name></DrugSynonyms><CompanyOriginator id="14691">Shire BioChem Inc</CompanyOriginator><CompaniesSecondary><Company id="14691">Shire BioChem Inc</Company><Company id="16881">Astra AB</Company></CompaniesSecondary><CrossReferences><SourceEntity id="8185" type="Drug"><TargetEntity id="211556" type="siDrug">BCH-1788</TargetEntity></SourceEntity><SourceEntity id="14691" type="Company"><TargetEntity id="4295860517" type="organizationId">Shire BioChem Inc</TargetEntity></SourceEntity><SourceEntity id="16881" type="Company"><TargetEntity id="5035884249" type="organizationId">AB Astra Apotekarnes Kemiska Fabriker</TargetEntity></SourceEntity><SourceEntity id="20" type="ciIndication"><TargetEntity id="10033371" type="MEDDRA"></TargetEntity><TargetEntity id="D010146" type="MeSH"></TargetEntity><TargetEntity id="-1585850437" type="omicsDisease"></TargetEntity><TargetEntity id="1" type="siCondition"></TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="DX">Discontinued</PhaseHighest><PhaseTerminated id="NDR">No Development Reported</PhaseTerminated><IndicationsSecondary><Indication id="20">Pain</Indication></IndicationsSecondary><ActionsSecondary><Action id="59620">Unspecified drug target</Action><Action id="2946">Analgesic</Action></ActionsSecondary><Technologies><Technology id="762">Small molecule therapeutic</Technology></Technologies><EphmraCodes><Ephmra><Code>N2</Code><Name>ANALGESICS</Name></Ephmra></EphmraCodes><LastModificationDate>2017-09-01T11:33:00.000Z</LastModificationDate><ChangeDateLast>2002-05-24T16:40:43.000Z</ChangeDateLast><AddedDate>1996-02-16T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;&lt;ulink linkID="8185" linkType="Drug"&gt;BCH-1788&lt;/ulink&gt; was under development by BioChem as a potential treatment for pain [&lt;ulink linkID="160477" linkType="reference"&gt;160477&lt;/ulink&gt;] but no development has been reported since 1994 [&lt;ulink linkID="160477" linkType="reference"&gt;160477&lt;/ulink&gt;].&lt;/para&gt;&lt;para&gt;Development of &lt;ulink linkID="8185" linkType="Drug"&gt;BCH-1788&lt;/ulink&gt; has now been discontinued.&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="16881">Astra AB</Company><Country id="WO">World</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="4">Not Reported</DiscontinuedReason><Indication id="20">Pain</Indication></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="14691">Shire BioChem Inc</Company><Country id="CA">Canada</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="4">Not Reported</DiscontinuedReason><Indication id="20">Pain</Indication></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="16881">Astra AB</Company><Country id="WO">World</Country><DevelopmentStatus id="NDR" sortOrder="3">No Development Reported</DevelopmentStatus><Indication id="20">Pain</Indication><Source id="160477" type="CORPORATE"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="14691">Shire BioChem Inc</Company><Country id="CA">Canada</Country><DevelopmentStatus id="NDR" sortOrder="3">No Development Reported</DevelopmentStatus><Indication id="20">Pain</Indication></DevelopmentStatusHistoric></IDdbDevelopmentStatus><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate></ReasonsForUpdate><hasSWOTs>N</hasSWOTs></drugRecordOutput>